Eva-Marie Jacobsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eva-Marie Jacobsen has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Per Morten Sandset
Department of Haematology, Oslo University Hospital and University of Oslo, Oslo, Norway
4 shared publications - Ida Kathrine Gravensteen
Department of Forensic Sciences, Oslo University Hospital, Box 4950 Nydalen, N-0424, Oslo, Norway
2 shared publications - Linda Björk Helgadottir
Department of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway
2 shared publications Per Morten Sandset
2 shared publications- Øivind Ekeberg
Department of Behavioural Sciences in Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
2 shared publications A. F. Jacobsen
Department of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway
1 shared publication
Latest Publications
- Open Access
- 24 January 2018
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 18 (1) , 1-10
Anxiety, depression and relationship satisfaction in the pregnancy following stillbirth and after the birth of a live-born baby: a prospective study
Experiencing a stillbirth can be a potent stressor for psychological distress in the subsequent pregnancy and possibly after the subsequent birth. The impact on women’s relationship with her partner in the subsequent pregnancy and postpartum remains uncertain. The objectives of the study were 1) To investigate the prevalence of anxiety and depression in the pregnancy following stillbirth and assess gestational age at stillbirth and inter-pregnancy interval as individual risk factors. 2) To assess the course of anxiety, depression and satisfaction with partner relationship up to 3 years after the birth of a live-born baby following stillbirth. This study is based on data from the Norwegian Mother and Child Cohort Study, a population-based pregnancy cohort. The sample included 901 pregnant women: 174 pregnant after a stillbirth, 362 pregnant after a live birth and 365 previously nulliparous. Anxiety and depression were assessed by short-form subscales of the Hopkins Symptoms Checklist, and relationship satisfaction was assessed by the Relationship Satisfaction Scale. These outcomes were measured in the third trimester of pregnancy and 6, 18 and 36 months postpartum. Logistic regression models were applied to study the impact of previous stillbirth on depression and anxiety in the third trimester of the subsequent pregnancy and to investigate gestational age and inter-pregnancy interval as potential risk factors. Women pregnant after stillbirth had a higher prevalence of anxiety (22.5%) and depression (19.7%) compared with women with a previous live birth (adjusted odds ratio (aOR) 5.47, 95% confidence interval (CI) 2.90–10.32 and aOR 1.91, 95% CI 1.11–3.27) and previously nulliparous women (aOR 4.97, 95% CI 2.68–9.24 and aOR 1.91, 95% CI 1.08–3.36). Gestational age at stillbirth (> 30 weeks) and inter-pregnancy interval < 12 months were not associated with depression and/or anxiety. Anxiety and depression decreased six to 18 months after the birth of a live-born baby, but increased again 36 months postpartum. Relationship satisfaction did not differ between groups. Women who have experienced stillbirth face a significantly greater risk of anxiety and depression in the subsequent pregnancy compared with women with a previous live birth and previously nulliparous women.
- 24 January 2018
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 18 (1) , 1-10
Open AccessAnxiety, depression and relationship satisfaction in the pregnancy following stillbirth and after the birth of a live-born baby: a prospective study
Experiencing a stillbirth can be a potent stressor for psychological distress in the subsequent pregnancy and possibly after the subsequent birth. The impact on women’s relationship with her partner in the subsequent pregnancy and postpartum remains uncertain. The objectives of the study were 1) To investigate the prevalence of anxiety and depression in the pregnancy following stillbirth and assess gestational age at stillbirth and inter-pregnancy interval as individual risk factors. 2) To assess the course of anxiety, depression and satisfaction with partner relationship up to 3 years after the birth of a live-born baby following stillbirth. This study is based on data from the Norwegian Mother and Child Cohort Study, a population-based pregnancy cohort. The sample included 901 pregnant women: 174 pregnant after a stillbirth, 362 pregnant after a live birth and 365 previously nulliparous. Anxiety and depression were assessed by short-form subscales of the Hopkins Symptoms Checklist, and relationship satisfaction was assessed by the Relationship Satisfaction Scale. These outcomes were measured in the third trimester of pregnancy and 6, 18 and 36 months postpartum. Logistic regression models were applied to study the impact of previous stillbirth on depression and anxiety in the third trimester of the subsequent pregnancy and to investigate gestational age and inter-pregnancy interval as potential risk factors. Women pregnant after stillbirth had a higher prevalence of anxiety (22.5%) and depression (19.7%) compared with women with a previous live birth (adjusted odds ratio (aOR) 5.47, 95% confidence interval (CI) 2.90–10.32 and aOR 1.91, 95% CI 1.11–3.27) and previously nulliparous women (aOR 4.97, 95% CI 2.68–9.24 and aOR 1.91, 95% CI 1.08–3.36). Gestational age at stillbirth (> 30 weeks) and inter-pregnancy interval < 12 months were not associated with depression and/or anxiety. Anxiety and depression decreased six to 18 months after the birth of a live-born baby, but increased again 36 months postpartum. Relationship satisfaction did not differ between groups. Women who have experienced stillbirth face a significantly greater risk of anxiety and depression in the subsequent pregnancy compared with women with a previous live birth and previously nulliparous women.
- Open Access
- 2 May 2016
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 84 (2) , 95-99
Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
Complement activation and low complement levels are common in systemic lupus erythematosus (SLE). Antiphospholipid antibodies (aPL) are found in about 30‐40% of patients withSLE. This study aimed to investigate the association betweenaPLand complement levels in patients withSLE. Serum samples were collected from 269 patients withSLEenrolled in the Norwegian Systemic Connective Tissue and Vasculitis Registry (NOSVAR) during 2003‐2009, and from 353 controls. All samples were analysed for anti‐β2 glycoprotein 1 (anti‐β2GP1) and anticardiolipin antibodies (aCL), C‐reactive protein (CRP) and complement components C3 and C4. MedianCRPlevel was significantly higher in cases than in controls (2.06 versus 0.90 mg/l;P < 0.0001). No significant difference inCRPwas found betweenSLEpatients with or withoutaPL(2.09 versus 1.89;P = 0.665). Median C3 levels were similar in cases (1.03 g/l) and controls (1.00 g/l), whereas median C4 levels were 0.16 g/l in cases versus. 0.19 in controls (P < 0.0001). However,aPL‐positiveSLEpatients had significantly lower median C3 levels (0.92 versus. 1.07 g/l;P = 0.001) and C4 levels (0.11 versus 0.16 g/l;P < 0.0001) compared toaPL‐negative patients. Lower C3 and C4 values inaPL‐positiveSLEpatients may reflect a higher consumption of C3 and C4 due to more pronounced complement activation inaPL‐positiveSLEpatients compared toSLEpatients withoutaPL.
- 2 May 2016
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 84 (2) , 95-99
Open AccessAntiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
Complement activation and low complement levels are common in systemic lupus erythematosus (SLE). Antiphospholipid antibodies (aPL) are found in about 30‐40% of patients withSLE. This study aimed to investigate the association betweenaPLand complement levels in patients withSLE. Serum samples were collected from 269 patients withSLEenrolled in the Norwegian Systemic Connective Tissue and Vasculitis Registry (NOSVAR) during 2003‐2009, and from 353 controls. All samples were analysed for anti‐β2 glycoprotein 1 (anti‐β2GP1) and anticardiolipin antibodies (aCL), C‐reactive protein (CRP) and complement components C3 and C4. MedianCRPlevel was significantly higher in cases than in controls (2.06 versus 0.90 mg/l;P < 0.0001). No significant difference inCRPwas found betweenSLEpatients with or withoutaPL(2.09 versus 1.89;P = 0.665). Median C3 levels were similar in cases (1.03 g/l) and controls (1.00 g/l), whereas median C4 levels were 0.16 g/l in cases versus. 0.19 in controls (P < 0.0001). However,aPL‐positiveSLEpatients had significantly lower median C3 levels (0.92 versus. 1.07 g/l;P = 0.001) and C4 levels (0.11 versus 0.16 g/l;P < 0.0001) compared toaPL‐negative patients. Lower C3 and C4 values inaPL‐positiveSLEpatients may reflect a higher consumption of C3 and C4 due to more pronounced complement activation inaPL‐positiveSLEpatients compared toSLEpatients withoutaPL.
- Open Access
- 13 May 2014
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 134 (9) , 924
Antikoagulasjon ved venøs trombose og indremedisinsk sykdom
De nye norske anbefalingene for profylakse og behandling av venøs trombose følger den siste oppdateringen fra American College of Chest Physicians' (ACCP) retningslinjer. Endringene som er gjort, skyldes enten et utvidet dokumentasjonsgrunnlag eller annen forståelse og vurdering ved svakt dokumentasjonsgrunnlag.
- 13 May 2014
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
- Vol. 134 (9) , 924
Open AccessAntikoagulasjon ved venøs trombose og indremedisinsk sykdom
De nye norske anbefalingene for profylakse og behandling av venøs trombose følger den siste oppdateringen fra American College of Chest Physicians' (ACCP) retningslinjer. Endringene som er gjort, skyldes enten et utvidet dokumentasjonsgrunnlag eller annen forståelse og vurdering ved svakt dokumentasjonsgrunnlag.
- Open Access
Women's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study
Objectives (1) To investigate the experiences of women with a previous stillbirth and their appraisal of the care they received at the hospital. (2) To assess the long-term level of post-traumatic stress symptoms (PTSS) in this group and identify risk factors for this outcome. Design A retrospective study. Setting Two university hospitals. Participants The study population comprised 379 women with a verified diagnosis of stillbirth (≥23 gestational weeks or birth weight ≥500 g) in a singleton or twin pregnancy 5–18 years previously. 101 women completed a comprehensive questionnaire in two parts. Primary and secondary outcome measures The women's experiences and appraisal of the care provided by healthcare professionals before, during and after stillbirth. PTSS at follow-up was assessed using the Impact of Event Scale (IES). Results The great majority saw (98%) and held (82%) their baby. Most women felt that healthcare professionals were supportive during the delivery (85.6%) and showed respect towards their baby (94.9%). The majority (91.1%) had received some form of short-term follow-up. One-third showed clinically significant long-term PTSS (IES ≥ 20). Independent risk factors were younger age (OR 6.60, 95% CI 1.99 to 21.83), induced abortion prior to stillbirth (OR 5.78, 95% CI 1.56 to 21.38) and higher parity (OR 3.46, 95% CI 1.19 to 10.07) at the time of stillbirth. Having held the baby (OR 0.17, 95% CI 0.05 to 0.56) was associated with less PTSS. Conclusions The great majority saw and held their baby and were satisfied with the support from healthcare professionals. One in three women presented with a clinically significant level of PTSS 5–18 years after stillbirth. Having held the baby was protective, whereas prior induced abortion was a risk factor for a high level of PTSS. Trial registration The study was registered at http://www.clinicaltrials.gov, with registration number NCT 00856076.
Open AccessWomen's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study
Objectives (1) To investigate the experiences of women with a previous stillbirth and their appraisal of the care they received at the hospital. (2) To assess the long-term level of post-traumatic stress symptoms (PTSS) in this group and identify risk factors for this outcome. Design A retrospective study. Setting Two university hospitals. Participants The study population comprised 379 women with a verified diagnosis of stillbirth (≥23 gestational weeks or birth weight ≥500 g) in a singleton or twin pregnancy 5–18 years previously. 101 women completed a comprehensive questionnaire in two parts. Primary and secondary outcome measures The women's experiences and appraisal of the care provided by healthcare professionals before, during and after stillbirth. PTSS at follow-up was assessed using the Impact of Event Scale (IES). Results The great majority saw (98%) and held (82%) their baby. Most women felt that healthcare professionals were supportive during the delivery (85.6%) and showed respect towards their baby (94.9%). The majority (91.1%) had received some form of short-term follow-up. One-third showed clinically significant long-term PTSS (IES ≥ 20). Independent risk factors were younger age (OR 6.60, 95% CI 1.99 to 21.83), induced abortion prior to stillbirth (OR 5.78, 95% CI 1.56 to 21.38) and higher parity (OR 3.46, 95% CI 1.19 to 10.07) at the time of stillbirth. Having held the baby (OR 0.17, 95% CI 0.05 to 0.56) was associated with less PTSS. Conclusions The great majority saw and held their baby and were satisfied with the support from healthcare professionals. One in three women presented with a clinically significant level of PTSS 5–18 years after stillbirth. Having held the baby was protective, whereas prior induced abortion was a risk factor for a high level of PTSS. Trial registration The study was registered at http://www.clinicaltrials.gov, with registration number NCT 00856076.
- Open Access
- 7 June 2012
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 12 (1) , 43
Long-term impact of intrauterine fetal death on quality of life and depression: a case–control study
Background: Intrauterine fetal death (IUFD) is a serious incidence that has been shown to impact mothers’ psychological well-being in the short-term. Long-term quality of life (QOL) and depression after IUFD is not known. This study aimed to determine the association between intrauterine fetal death and long-term QOL, well-being, and depression.Methods: Analyses were performed on collected data among 106 women with a history of intrauterine fetal death (IUFD) and 262 women with live births, 5–18 years after the event. Univariable and multivariable linear and logistic regression models were used to quantify the association between previous fetal death and long-term QOL, well-being and depression. QOL was assessed using the QOL Index (QLI), symptoms of depression using the Center for Epidemiological Studies Depression Scale (CES-D), and subjective well-being using the General Health Questionnaire 20 (GHQ-20).Results: More of the cases had characteristics associated with lower socioeconomic status and did not rate their health as good as did the controls. The QLI health and functioning subscale score was slightly but significantly lower in the cases than in the controls (22.3. vs 23.5,P = .023). The CES-D depressed affect subscale score (2.0 vs 1.0,P = 0.004) and the CES-D global score (7.4 vs 5.0,P = .017) were higher in the cases. Subjective well-being did not differ between groups (20.6 vs 19.4,P = .094). After adjusting for demographic and health-related variables, IUFD was not associated with global QOL (P = .674), subjective well-being (P = .700), or global depression score (adjusted odds ratio = 0.77, 95% confidence interval 0.37–1.57).Conclusions: Women with previous IUFD, of which the majority have received short-term interventions, share the same level of long-term QOL, well-being and global depression as women with live births only, when adjusted for possible confounders.Trial registration: The study was registered athttp://www.clinicaltrials.gov, with registration number NCT 00856076.
- 7 June 2012
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 12 (1) , 43
Open AccessLong-term impact of intrauterine fetal death on quality of life and depression: a case–control study
Background: Intrauterine fetal death (IUFD) is a serious incidence that has been shown to impact mothers’ psychological well-being in the short-term. Long-term quality of life (QOL) and depression after IUFD is not known. This study aimed to determine the association between intrauterine fetal death and long-term QOL, well-being, and depression.Methods: Analyses were performed on collected data among 106 women with a history of intrauterine fetal death (IUFD) and 262 women with live births, 5–18 years after the event. Univariable and multivariable linear and logistic regression models were used to quantify the association between previous fetal death and long-term QOL, well-being and depression. QOL was assessed using the QOL Index (QLI), symptoms of depression using the Center for Epidemiological Studies Depression Scale (CES-D), and subjective well-being using the General Health Questionnaire 20 (GHQ-20).Results: More of the cases had characteristics associated with lower socioeconomic status and did not rate their health as good as did the controls. The QLI health and functioning subscale score was slightly but significantly lower in the cases than in the controls (22.3. vs 23.5,P = .023). The CES-D depressed affect subscale score (2.0 vs 1.0,P = 0.004) and the CES-D global score (7.4 vs 5.0,P = .017) were higher in the cases. Subjective well-being did not differ between groups (20.6 vs 19.4,P = .094). After adjusting for demographic and health-related variables, IUFD was not associated with global QOL (P = .674), subjective well-being (P = .700), or global depression score (adjusted odds ratio = 0.77, 95% confidence interval 0.37–1.57).Conclusions: Women with previous IUFD, of which the majority have received short-term interventions, share the same level of long-term QOL, well-being and global depression as women with live births only, when adjusted for possible confounders.Trial registration: The study was registered athttp://www.clinicaltrials.gov, with registration number NCT 00856076.
- Open Access
- 26 April 2012
- Published by Wiley in British Journal of Haematology
- Vol. 157 (6) , 753-761
Candidate gene polymorphisms and the risk for pregnancy‐related venous thrombosis
Summary: Venous thrombosis (VT) is one of the leading causes of maternal death in the western world, but the genetic causes of pregnancy‐relatedVTare insufficiently understood. The aim of this study was to investigate the association between common genetic variations in candidate genes and pregnancy‐relatedVT. We undertook a hospital based case–control study of women withVTduring pregnancy or puerperium; controls were women giving birth without havingVT. Single nucleotide polymorphisms (SNPs) were selected in 49 pre‐specified candidate genes involved in coagulation, inflammation, and hormonal metabolism in 313 cases and 353 controls. We found new associations betweenSNPs and total pregnancy‐relatedVTin the genes encoding coagulation factorsVandVIII, and p‐selectin. Additional new associations betweenSNPs and antenatalVTwere found in the genes encoding the epidermal growth factor receptor, the pregnaneXreceptor, and proteinS. Of 21SNPs previously associated with thrombotic disease, rs2289252 inF11and rs3917643 inF3were associated with pregnancy‐relatedVT, while rs4524 inF5was associated with antenatalVT.
- 26 April 2012
- Published by Wiley in British Journal of Haematology
- Vol. 157 (6) , 753-761
Open AccessCandidate gene polymorphisms and the risk for pregnancy‐related venous thrombosis
Summary: Venous thrombosis (VT) is one of the leading causes of maternal death in the western world, but the genetic causes of pregnancy‐relatedVTare insufficiently understood. The aim of this study was to investigate the association between common genetic variations in candidate genes and pregnancy‐relatedVT. We undertook a hospital based case–control study of women withVTduring pregnancy or puerperium; controls were women giving birth without havingVT. Single nucleotide polymorphisms (SNPs) were selected in 49 pre‐specified candidate genes involved in coagulation, inflammation, and hormonal metabolism in 313 cases and 353 controls. We found new associations betweenSNPs and total pregnancy‐relatedVTin the genes encoding coagulation factorsVandVIII, and p‐selectin. Additional new associations betweenSNPs and antenatalVTwere found in the genes encoding the epidermal growth factor receptor, the pregnaneXreceptor, and proteinS. Of 21SNPs previously associated with thrombotic disease, rs2289252 inF11and rs3917643 inF3were associated with pregnancy‐relatedVT, while rs4524 inF5was associated with antenatalVT.
- Open Access
- 25 January 2006
- Published by Springer Nature in Thrombosis Journal
- Vol. 4 (1) , 3
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
Background: Lupus anticoagulants prolong clotting times in phospholipid-dependent coagulation tests. Lupus Ratio assays are integrated tests for lupus anticoagulants that may be based on APTT, RVVT or dPT clotting times. If a patient is being treated with unfractionated heparin, however, the heparin prolong clotting times and the diagnosis of lupus anticoagulant is invalidated. Commercial assays may have heparin neutralising agents added to their reagents. However, the type and efficacy of the heparin neutralisation is often not documented. We wanted to test the influence and efficacy of heparin neutralisers in the Lupus Ratio assay. Methods: Several heparin neutralisers were tested, and polybrene was chosen for further testing. Unfractionated heparin and/or polybrene were added to normal plasma and to plasma from patients with or without lupus anticoagulant and clotting times compared before and after the additions. Lupus anticoagulant-positive patients were given 5000 IU i.v. of unfractionated heparin and plasma was collected just before and five minutes after the injection. Lupus Ratios were calculated after polybrene was added to the postinjection samples. Results: The Lupus Ratio became slightly lower when polybrene was added to plasma without heparin. Plasma heparinised in vitro and plasma from patients that had received heparin, both had Lupus Ratios nearly identical to the Lupus Ratios calculated before any additions. Conclusion: By addition of polybrene to a final concentration of 7.9 μg/ml in test plasma, Lupus Ratio may be determined in lupus anticoagulant-negative as well as positive plasmas irrespective of the presence of heparin 0.0 – 1.3 U/ml.
- 25 January 2006
- Published by Springer Nature in Thrombosis Journal
- Vol. 4 (1) , 3
Open AccessDetection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
Background: Lupus anticoagulants prolong clotting times in phospholipid-dependent coagulation tests. Lupus Ratio assays are integrated tests for lupus anticoagulants that may be based on APTT, RVVT or dPT clotting times. If a patient is being treated with unfractionated heparin, however, the heparin prolong clotting times and the diagnosis of lupus anticoagulant is invalidated. Commercial assays may have heparin neutralising agents added to their reagents. However, the type and efficacy of the heparin neutralisation is often not documented. We wanted to test the influence and efficacy of heparin neutralisers in the Lupus Ratio assay. Methods: Several heparin neutralisers were tested, and polybrene was chosen for further testing. Unfractionated heparin and/or polybrene were added to normal plasma and to plasma from patients with or without lupus anticoagulant and clotting times compared before and after the additions. Lupus anticoagulant-positive patients were given 5000 IU i.v. of unfractionated heparin and plasma was collected just before and five minutes after the injection. Lupus Ratios were calculated after polybrene was added to the postinjection samples. Results: The Lupus Ratio became slightly lower when polybrene was added to plasma without heparin. Plasma heparinised in vitro and plasma from patients that had received heparin, both had Lupus Ratios nearly identical to the Lupus Ratios calculated before any additions. Conclusion: By addition of polybrene to a final concentration of 7.9 μg/ml in test plasma, Lupus Ratio may be determined in lupus anticoagulant-negative as well as positive plasmas irrespective of the presence of heparin 0.0 – 1.3 U/ml.